Why Milestone Scientific Inc.’s (MLSS) Stock Is Down 5.80%

By Cynthia McLaughlin
September 03, 2026
Featured Tickers:

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Milestone Scientific Inc. before investing.

In this article, we go over a few key elements for understanding Milestone Scientific Inc.’s stock price such as:

  • Milestone Scientific Inc.’s current stock price and volume
  • Why Milestone Scientific Inc.’s stock price changed recently
  • Upgrades and downgrades for MLSS from analysts
  • MLSS’s stock price momentum as measured by its relative strength

About Milestone Scientific Inc. (MLSS)

Before we jump into Milestone Scientific Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company provides The Wand, a single use disposable handpiece device for dental procedures that require local anesthetic under the CompuDent and STA Single Tooth Anesthesia System names. It also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, the company provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Further, it offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

Want to learn more about Milestone Scientific Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Milestone Scientific Inc..

Learn More About A+ Investor

Milestone Scientific Inc.’s Stock Price as of Market Close

As of September 03, 2026, 12:01 PM, CST, Milestone Scientific Inc.’s stock price was $0.473.

Milestone Scientific Inc. is up 1.88% from its previous closing price of $0.464.

During the last market session, Milestone Scientific Inc.’s stock traded between $0.450 and $0.480. Currently, there are approximately 93.13 million shares outstanding for Milestone Scientific Inc..

Milestone Scientific Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Milestone Scientific Inc. Stock Price History

Milestone Scientific Inc.’s (MLSS) price is currently down 0.88% so far this month.

During the month of September, Milestone Scientific Inc.’s stock price has reached a high of $0.490 and a low of $0.450.

Over the last year, Milestone Scientific Inc. has hit prices as high as $0.647 and as low as $0.218. Year to date, Milestone Scientific Inc.’s stock is up 73.11%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Milestone Scientific Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 02, 2026, there were analysts who downgraded Milestone Scientific Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Milestone Scientific Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Milestone Scientific Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Milestone Scientific Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Milestone Scientific Inc. (MLSS) by visiting AAII Stock Evaluator.

Relative Price Strength of Milestone Scientific Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 02, 2026, Milestone Scientific Inc. has a weighted four-quarter relative price strength of -3.39%, which translates to a Momentum Score of 39 and is considered to be Weak.

Want to learn more about how Milestone Scientific Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Milestone Scientific Inc. Stock Price: Bottom Line

As of September 3, 2026, Milestone Scientific Inc.’s stock price is $0.473, which is up 1.88% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Milestone Scientific Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
High Relative Dividend
Yield Screen:
8.7% Compared to S&P 500
at only 6.9%

Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.